.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Johnson and Johnson
Dow
Citi
Cerilliant
Colorcon
Cipla
Merck
Julphar

Generated: September 20, 2017

DrugPatentWatch Database Preview

ALINIA Drug Profile

« Back to Dashboard

What is the patent landscape for Alinia, and when can generic versions of Alinia launch?

Alinia is a drug marketed by Romark and is included in two NDAs. There are three patents protecting this drug.

This drug has one hundred and twenty-three patent family members in forty-two countries.

The generic ingredient in ALINIA is nitazoxanide. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nitazoxanide profile page.

Summary for Tradename: ALINIA

Patents:3
Applicants:1
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list76
Clinical Trials: see list17
Patent Applications: see list1,001
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALINIA at DailyMed

Pharmacology for Tradename: ALINIA

Drug ClassAntiprotozoal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004RXYesYes► Subscribe► SubscribeY ► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ALINIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
TABLET;ORAL021497-001Jul 21, 2004► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
Romark
ALINIA
nitazoxanide
FOR SUSPENSION;ORAL021498-001Nov 22, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: ALINIA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,387,598 Composition and galenic formulation suitable for combatting affections of the lower abdomen► Subscribe
5,886,013 Antiviral composition► Subscribe
5,859,038 Method for treatment of helicobacter pylori infections► Subscribe
5,856,348 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide► Subscribe
5,578,621 Benzamide derivatives► Subscribe
6,051,576 Means to achieve sustained release of synergistic drugs by conjugation► Subscribe
6,020,353 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ALINIA

Country Document Number Estimated Expiration
African Regional IP Organization (ARIPO)9901675► Subscribe
African Intellectual Property Organization (OAPI)11169► Subscribe
Poland186504► Subscribe
Japan3739802► Subscribe
Cuba22990► Subscribe
China1158074► Subscribe
Slovakia151199► Subscribe
Australia689582► Subscribe
China1145621► Subscribe
Bulgaria62932► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Merck
Teva
US Department of Justice
McKesson
Farmers Insurance
QuintilesIMS
Healthtrust
Covington
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot